Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes digital illustration

Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes Save


ICD-10 code: C81.42

Disease category: C81.4: Lymphocyte-rich Hodgkin lymphoma

Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes

Lymphocyte-rich Hodgkin lymphoma (LRHL) is a subtype of Hodgkin lymphoma characterized by the presence of an abundance of lymphocytes within the tumor tissue. This variant is relatively rare, accounting for only a small percentage of Hodgkin lymphoma cases. LRHL primarily affects the intrathoracic lymph nodes, which are located in the chest area.

LRHL is considered a favorable subtype of Hodgkin lymphoma due to its relatively good prognosis. Patients with LRHL generally have a higher survival rate compared to other variants of the disease. However, it is essential to note that individual cases may vary, and the overall outlook depends on various factors.

The intrathoracic lymph nodes are a group of lymph nodes found in the chest cavity. These lymph nodes play a crucial role in filtering lymph fluid and assisting in immune system function. In LRHL, the intrathoracic lymph nodes become infiltrated with abnormal cells, including Reed-Sternberg cells and a high number of lymphocytes.

Diagnosing LRHL involves a combination of clinical examination, imaging tests such as CT scans or PET scans, and the analysis of biopsy samples taken from affected lymph nodes. The presence of lymphocyte-rich tissue, along with the characteristic Reed-Sternberg cells, helps distinguish LRHL from other types of Hodgkin lymphoma.

  1. LRHL typically presents with symptoms such as:
    • Swollen lymph nodes in the chest area
    • Chest pain
    • Shortness of breath
    • Fever
    • Night sweats
  2. LRHL is more common in younger adults, with a peak incidence between the ages of 20 and 40.
  3. LRHL has a favorable response to treatment, often involving chemotherapy and radiation therapy.

In conclusion, lymphocyte-rich Hodgkin lymphoma primarily affects the intrathoracic lymph nodes in the chest area. It is a relatively rare subtype of Hodgkin lymphoma with a favorable prognosis. Diagnosing LRHL involves evaluating clinical symptoms, imaging tests, and biopsy samples. Treatment options typically include chemotherapy and radiation therapy. If you experience any concerning symptoms, it is important to consult with a medical professional for proper evaluation and diagnosis.

Treatment of Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes:

Treatment Options for Lymphocyte-rich Hodgkin Lymphoma, Intrathoracic Lymph Nodes

Lymphocyte-rich Hodgkin lymphoma (LRHL) is a subtype of Hodgkin lymphoma characterized by an abundance of lymphocytes in the affected tissue. When LRHL affects the intrathoracic lymph nodes, it requires prompt diagnosis and appropriate treatment to ensure the best possible outcome.

There are s...

To see full information about treatment please Sign up or Log in